DK645687A - Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine - Google Patents

Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine

Info

Publication number
DK645687A
DK645687A DK645687A DK645687A DK645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A
Authority
DK
Denmark
Prior art keywords
vaccine
preparing
procedure
zonal
subjected
Prior art date
Application number
DK645687A
Other languages
English (en)
Other versions
DK645687D0 (da
Inventor
Philippe Jean Adamowicz
Marie Noelle Mevelec
Marc Girard
Original Assignee
Pasteur Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins
Publication of DK645687D0 publication Critical patent/DK645687D0/da
Publication of DK645687A publication Critical patent/DK645687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK645687A 1986-12-10 1987-12-09 Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine DK645687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617265A FR2608052B1 (fr) 1986-12-10 1986-12-10 Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu

Publications (2)

Publication Number Publication Date
DK645687D0 DK645687D0 (da) 1987-12-09
DK645687A true DK645687A (da) 1988-06-11

Family

ID=9341743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645687A DK645687A (da) 1986-12-10 1987-12-09 Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine

Country Status (11)

Country Link
EP (1) EP0273811B1 (da)
JP (1) JPS63215639A (da)
KR (1) KR880007732A (da)
AT (1) ATE109353T1 (da)
CA (1) CA1306689C (da)
DE (1) DE3750330T2 (da)
DK (1) DK645687A (da)
FR (1) FR2608052B1 (da)
IL (1) IL84729A (da)
NO (1) NO171147C (da)
PT (1) PT86321B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073604A (zh) * 1991-12-01 1993-06-30 高真南 制备高免疫原性乙型肝炎疫苗的方法
WO1993012815A1 (fr) * 1991-12-27 1993-07-08 Gensci Limited Procede d'obtention d'un antigene de surface recombine de l'hepatite b, antigene et vaccin a base de celui-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Also Published As

Publication number Publication date
NO171147C (no) 1993-02-03
NO171147B (no) 1992-10-26
EP0273811A3 (en) 1988-08-03
JPS63215639A (ja) 1988-09-08
PT86321B (pt) 1990-11-07
NO875142D0 (no) 1987-12-09
FR2608052A1 (fr) 1988-06-17
CA1306689C (en) 1992-08-25
FR2608052B1 (fr) 1990-04-13
ATE109353T1 (de) 1994-08-15
KR880007732A (ko) 1988-08-29
NO875142L (no) 1988-06-13
DE3750330D1 (de) 1994-09-08
DK645687D0 (da) 1987-12-09
IL84729A (en) 1993-02-21
EP0273811A2 (fr) 1988-07-06
EP0273811B1 (fr) 1994-08-03
PT86321A (fr) 1988-01-01
DE3750330T2 (de) 1994-11-17
IL84729A0 (en) 1988-05-31

Similar Documents

Publication Publication Date Title
EP0584348A4 (en) Genetic vaccine for immunodeficiency viruses
CA2272046A1 (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
NO167359C (no) Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
AU5572786A (en) Expression of immunologically reactive aids viral protein
DK27287D0 (da) Fremgangsmaade til fremstilling af pertussisantigener
DK482788D0 (da) Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
DK645687A (da) Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine
AU2865084A (en) Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
ATE179428T1 (de) Verfahren zur herstellung von hepatitis antigenen und impfstoffen
AU4817885A (en) Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
DK0480525T3 (da) Fremgangsmåde til opnåelse af rekombinant hepatitis B virus (HEP B) overfladeantigen med større immunogen kapacitet og anve
EP0199480A3 (en) Hepatitis a virus vaccines
FR2604183B1 (fr) Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
DK312687D0 (da) Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzv
DK0408742T3 (da) Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine
Gerin et al. Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
Michel et al. Synthesis and secretion of hepatitis-B surface antigen particles in transfected animal cells.
PT72045B (en) Process for preparing vaccines for swine protection
Leboulleux et al. Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
BR9705324C1 (pt) Método para produção de hbsag purificado para preparação de vacina e vacina recombinante contra a hepatite do tipo b
AR212170A1 (es) Medio de cultivo de celulas para la produccion de virus utilizables en la elaboracion de vacunas y un procedimiento para la preparacion de una vacuna mediante dicho medio de cultivo

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment